Health · 1 sources covering this

STAT+: New treatments for common cardiovascular risk factor near the market, with billions at stake

High cholesterol can be managed with medicine, but high Lp(a) levels, another common cardiovascular risk, cannot. Drugmakers are hoping to change that.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·1h ago
STAT+: New treatments for common cardiovascular risk factor near the market, with billions at stake
High cholesterol can be managed with medicine, but high Lp(a) levels, another common cardiovascular risk, cannot. Drugmakers are hoping to change that.
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/c7efdd1bd579bdef65954bf2b40ab5600f812590"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: New treatments for common cardiovascular risk factor near the market, with billions at stake"></iframe>

STAT+: New treatments for common cardiovascular risk factor near the market, with billions at stake

How 1 sources are covering this

STAT+: New treatments for common cardiovascular risk factor near the market, with billions at stake

More from Health

COMIC: 7 lifestyle habits that may boost your chances of getting pregnant

Newer shingles vaccine linked to lower heart disease risk, ‘natural experiment’ shows

Trump Puts Autistic Kids in the Spotlight and Cuts Agencies Built To Protect Them

Her Breast MRI Was Approved, But That Didn’t Mean Her Insurance Would Pay

Reader

Trust & legal

Across the network